Netherlands Heart Journal

29th Congress of the European Society of Cardiology

• Preface

Hot line 1

• Hot lines

J. P. Ottervanger

Hot line II

• Hot lines

H. M. Nathoe

Hot line III

• Hot lines

A. J. Teske, J. S. S. G. de Jong

Clinical trial update I

• Clinical trial updates

P. G. Postema

Clinical trial update II

• Clinical trial updates

E. E. van der Wall

Past, present and future of ACE inhibitors

• Satellite symposia

S. G. Molhoek

The bridge to achieving the greater LDL-C goal of <70 mg/dl: inhibiting cholesterol absorption and production

• Satellite symposia

A. H. E. M. Maas

The future of interventional therapy in cardiology

• Satellite symposia

L. F. Tops

Echocardiography: a new window for the heart

• Satellite symposia

N. Marsan Ajmone

If inhibition: the new strategy in cardiovascular risk management

• Satellite symposia

I. R. Henkens

Setting the standard in pulmonary hypertension management

• Satellite symposia

S. G. Molhoek, H. W. Vliegen

New evidence in the management of cardiovascular risk: the place of heart rate

• Satellite symposia

D. A. Pijnappels

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

• Satellite symposia

M. V. Huisman

Innovative device technologies for optimised heart failure management

• Satellite symposia

J. A. Kragten

Highlight session

• Highlight session

C. Ypenburg